SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    RiesLAG, SmithMA, GurneyJG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. NIH Pub. No. 99-4649. Bethesda, Md: National Institutes of Health; 1999.
  • 2
    Dyer MA, Rodriguez-Galindo C, Wilson MW. Use of preclinical models to improve treatment of retinoblastoma [serial online]. PLoS Med. 2005; 2: e332.
  • 3
    Laurie NA, Donovan SL, Shih CS, et al. Inactivation of the p53 pathway in retinoblastoma. Nature. 2006; 444: 61-66.
  • 4
    Laurie NA, Gray JK, Zhang J, et al. Topotecan combination chemotherapy in 2 new rodent models of retinoblastoma. Clin Cancer Res. 2005; 11: 7569-7578.
  • 5
    Athale UH, Stewart C, Kuttesch JF, et al. Phase I study of combination topotecan and carboplatin in pediatric solid tumors. J Clin Oncol. 2002; 20: 88-95.
  • 6
    Abramson DH, Frank CM, Dunkle IJ. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma. Ophthalmology. 1999; 106: 1947-1950.
  • 7
    Zhang J, Schweers B, Dyer MA. The first knockout mouse model of retinoblastoma. Cell Cycle. 2004; 3: 952-959.
  • 8
    McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res. 1977; 37: 1003-1010.
  • 9
    Shih CS, Laurie N, Holzmacher J, et al. AAV-mediated local delivery of interferon-β for the treatment of retinoblastoma in preclinical models. Neuromolecular Med. 2009; 11: 43-52.
  • 10
    Thompson J, George EO, Poquette CA, et al. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Clin Cancer Res. 1999; 5: 3617-3631.
  • 11
    D'Argenio DZ, Schumitzky A. ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Los Angeles, Calif: Biomedical Simulations Resource; 2006.
  • 12
    Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci. 2004; 45: 4611-4616.
  • 13
    Chantada GL, Fandino AC, Carcaboso AM, et al. A phase I study of periocular topotecan in children with intraocular retinoblastoma. Invest Ophthalmol Vis Sci. 2009; 50: 1492-1496.